# Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor

> **NCT06088212** · NA · RECRUITING · sponsor: **Baker Heart and Diabetes Institute** · enrollment: 168 (estimated)

## Conditions studied

- Heart Failure
- Cognitive Impairment
- Dementia
- Left Ventricular Dysfunction
- Cognitive Change
- Cognitive Decline

## Interventions

- **OTHER:** Disease management program

## Key facts

- **NCT ID:** NCT06088212
- **Lead sponsor:** Baker Heart and Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-10
- **Final completion:** 2026-07
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06088212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06088212, "Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06088212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*